Literature DB >> 22535972

Iodotyrosine deiodinase defect identified via genome-wide approach.

Agnès Burniat1, Isabelle Pirson, Catheline Vilain, Willem Kulik, Gijs Afink, Rodrigo Moreno-Reyes, Bernard Corvilain, Marc Abramowicz.   

Abstract

CONTEXT: Diagnosis of congenital hypothyroidism is hampered by the heterogeneity of inborn errors of thyroid metabolism and the possible delay in hypothyroidism development leading to missed cases by neonatal screen.
OBJECTIVE: In the current study, we used a whole-genome approach to identify the mutation responsible for severe hypothyroidism and a huge goiter in the eldest child born to healthy first cousins.
RESULTS: We identified a homozygous mutation of the iodotyrosine deiodinase gene (IYD). We delineated the phenotype of this defect in detail, including urinary monoiodotyrosine (MIT) and diiodotyrosine (DIT) excretion. Moreover, a 4.5-yr-old sister was found homozygous for the mutation. Her clinical and biological data were normal, except for elevated MIT and DIT excretion. The urinary loss of MIT and DIT iodine observed in most affected individuals was quite limited compared to the total iodine loss, except for the hypothyroid homozygote. Hypothyroidism could therefore be partially induced by a relative iodine deficiency caused by urinary iodine loss through MIT and DIT excretion, even in cases of normal iodine intake. The wide inter- and intrafamilial variability of the disease severity remains unclear.
CONCLUSIONS: Besides refining the phenotype of the IYD defect, our observation shows that a global, genome-wide approach to the heterogeneous inborn thyroid defects was efficient in rapidly identifying the mutation in the proband and the disease recurrence in the still euthyroid sister. Although facilitated by consanguinity in this family, novel sequencing techniques will soon make whole-genome approaches readily amenable to more common cases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22535972     DOI: 10.1210/jc.2011-3314

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Genetic counselors' views and experiences with the clinical integration of genome sequencing.

Authors:  Kalotina Machini; Jessica Douglas; Alicia Braxton; Judith Tsipis; Kate Kramer
Journal:  J Genet Couns       Date:  2014-03-28       Impact factor: 2.537

Review 2.  Impact of Chemical Endocrine Disruptors and Hormone Modulators on the Endocrine System.

Authors:  Valentina Guarnotta; Roberta Amodei; Francesco Frasca; Antonio Aversa; Carla Giordano
Journal:  Int J Mol Sci       Date:  2022-05-20       Impact factor: 6.208

Review 3.  EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals.

Authors:  A C Gore; V A Chappell; S E Fenton; J A Flaws; A Nadal; G S Prins; J Toppari; R T Zoeller
Journal:  Endocr Rev       Date:  2015-11-06       Impact factor: 19.871

4.  Increased Prevalence of TG and TPO Mutations in Sudanese Children With Congenital Hypothyroidism.

Authors:  Ryan J Bruellman; Yui Watanabe; Reham S Ebrhim; Matthew K Creech; Mohamed A Abdullah; Alexandra M Dumitrescu; Samuel Refetoff; Roy E Weiss
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

5.  Antibodies Regulate Dual-Function Enzyme IYD to Induce Functional Synergy between Metabolism and Thermogenesis.

Authors:  Sunghyun Kang; Hwan-Woo Park; Kyung Ho Han
Journal:  Int J Mol Sci       Date:  2022-07-15       Impact factor: 6.208

6.  Agonist Antibody Converts Stem Cells into Migrating Brown Adipocyte-Like Cells in Heart.

Authors:  Kyung Ho Han; Britni M Arlian; Chih-Wei Lin; Hyun Yong Jin; Geun-Hyung Kang; Sahmin Lee; Peter Chang-Whan Lee; Richard A Lerner
Journal:  Cells       Date:  2020-01-20       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.